GlassScriptPhysician profile
Esther Ozeryansky
NPI 1255624219
$948.39
in general payments reported to CMS, 2019-2025
11 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.27 · 2020: $13.67 · 2021: $192 · 2022: $120 · 2023: $134 · 2024: $209 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $172.44 | 2021-2023 | Myrisk |
| Merck Sharp & Dohme LLC | $154.73 | 2022-2025 | Keytruda, Lynparza |
| Musculoskeletal Transplant Foundation INC. | $132.97 | 2021-2025 | |
| Tactile Systems Technology INC | $116.62 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Hologic Sales and Service, LLC | $102.37 | 2024 | Trident Specimen Radiography System |
| Kci USA, INC. | $83.17 | 2021-2023 | Prevena |
| Davol INC. | $65.23 | 2021-2025 | Arista |
| Kub Technologies INC. | $42.79 | 2024 | |
| Smith+Nephew, INC. | $39.34 | 2019 | |
| Conmed Corporation | $22.34 | 2025 | Abc Handpieces, Visiclear |
| Convatec INC. | $16.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Esther Ozeryansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.